Location History:
- Bad Honningen, DE (1999)
- Bad Honningen/Ariendorf, DE (1998 - 2000)
- Bad Hönningen/Ariendorf, DE (2003)
- Bad Hönningen, DE (2001 - 2004)
- Rheinbrohl, DE (2009 - 2014)
- Bad Breisig, DE (2022 - 2024)
Company Filing History:
10 out of 317 
4 out of 54 
1 out of 2,937 
Years Active: 1998-2025
Title: Frank Seibertz: Pioneering Innovator in Transdermal Delivery Systems for Pharmaceutical and Veterinary Medicine
Introduction:
Frank Seibertz, an esteemed inventor hailing from Rheinbrohl, Germany, has made significant contributions to the fields of pharmaceutical and veterinary medicine through his pioneering work in transdermal delivery systems. With 11 patents to his name, Frank Seibertz has garnered recognition for his innovative solutions that have improved the administration of active substances. This article delves into his latest patents, career highlights, and notable collaborations, highlighting his remarkable contributions to the field.
Latest Patents:
One of Frank Seibertz's groundbreaking inventions is the Buprenorphine Transdermal Delivery System. This system comprises a buprenorphine-containing adhesive layer structure, featuring a buprenorphine-impermeable backing layer and a buprenorphine-containing pressure-sensitive adhesive layer. The adhesive layer incorporates a polymer-based pressure-sensitive adhesive, buprenorphine base or its pharmaceutically acceptable salt, a viscosity-increasing substance, and a carboxylic acid. This patent revolutionizes the transdermal administration of buprenorphine, providing an effective and convenient delivery method.
Another notable innovation by Frank Seibertz is the Mucoadhesive Dispersible Pharmaceutical Preparation for Active-Agent Dosing in Veterinary and Human Medicine. This invention presents a mucoadhesive matrix that disintegrates or erodes within 15 minutes in aqueous media. The preparation, containing matrix-forming polymers and dissolved or dispersed active substances, contributes to efficient and fast administration in veterinary and human medicine. This patent emphasizes Frank Seibertz's commitment to improving drug delivery methods.
Career Highlights:
Frank Seibertz's career showcases his expertise in the field of pharmaceutical and veterinary medicine innovations. Notably, he has worked with renowned companies such as Lts Lohmann Therapie-Systeme AG, a global leader in transdermal therapeutic systems. Through his collaboration with Lts Lohmann, Frank Seibertz has played a crucial role in developing cutting-edge drug delivery solutions.
Collaborations:
Throughout his career, Frank Seibertz has had the privilege of collaborating with accomplished individuals in his field. Notable coworkers include Reinhold Meconi and Tina Rademacher, both accomplished professionals who have contributed to the advancement of pharmaceutical and veterinary medicine. These collaborations have fostered a creative environment for sharing knowledge and expertise, leading to innovative solutions.
Conclusion:
Frank Seibertz's dedication and expertise in the field of pharmaceutical and veterinary medicine innovations have contributed to significant advancements in drug delivery systems. His latest patents, including the Buprenorphine Transdermal Delivery System and the Mucoadhesive Dispersible Pharmaceutical Preparation, demonstrate his commitment to improving the administration of active substances. Through his collaborations and career highlights, Frank Seibertz has solidified his position as a pioneering inventor. His work continues to shape the future of transdermal drug delivery, benefiting both human and veterinary patients worldwide.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.